Caring Brands (CABR) Total Current Liabilities (2024 - 2026)

Caring Brands (CABR) posted quarterly Total Current Liabilities of $384473.0 for Q1 2026, up 117.41% quarter-over-quarter from $176844.0 in Q4 2025.

Caring Brands (CABR) Total Current Liabilities (2024 - 2026) Analysis & Trends

Caring Brands' Total Current Liabilities history runs 3 years deep, the most recent figure standing at $384473.0 for Q1 2026.

In Q1 2026, Total Current Liabilities changed N/A year-over-year to $384473.0; the TTM figure through Mar 2026 stood at $384473.0 (changed N/A YoY), while the FY2025 annual figure was $176844.0, down 4.98% from the prior year.
Total Current Liabilities for Q1 2026 stood at $384473.0, up from $176844.0 in the prior quarter.
The five-year high for Total Current Liabilities was $570210.0 in Q3 2025, with the low at $176844.0 in Q4 2025.
The 3-year median for Total Current Liabilities is $285289.0 (2024), against an average of $329408.0.
Peak annual rise in Total Current Liabilities reached 4.98% in 2025, while the deepest fall reached 4.98% in 2025.
Caring Brands' Total Current Liabilities stood at $186105.0 in 2024, then slipped by 4.98% to $176844.0 in 2025, then soared by 117.41% to $384473.0 in 2026.
Business Quant data shows CABR's Total Current Liabilities at $384473.0 in Q1 2026, $176844.0 in Q4 2025, and $570210.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Current Liabilities (Qtr)
1	Haleon	44.51 Bn	43.55 Bn	-	-8.38 Bn
2	Teva Pharmaceutical Industries	43.52 Bn	39.86 Bn	2.15 Bn	15.65 Bn
3	Zoetis	32.43 Bn	30.75 Bn	1.05 Bn	2.06 Bn
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	17.34 Bn
5	United Therapeutics	21.87 Bn	19.21 Bn	683.80 Mn	607.80 Mn
6	Viatris	18.98 Bn	18.09 Bn	1.46 Bn	6.35 Bn
7	Neurocrine Biosciences	15.43 Bn	15.04 Bn	935.80 Mn	874.50 Mn
8	Elanco Animal Health	12.02 Bn	11.49 Bn	798.00 Mn	1.85 Bn
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-	1.79 Bn
10	Caring Brands	11.69 Mn	9.87 Mn	-	384,646.00

Download Data